Certificate number:RU.77.99.32.003.E.010219.11.15
Date of registration and renewal:18.11.2015
Dosage form: & nbspcapsules of 500 mg ± 10%, tablets weighing 500 mg ± 10%
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Classification "Clinical" & nbsp BAD-sources of multivitamins containing individual minerals and mineral complexes
Composition: & nbspBiologically active components, mg / caps. / Tab .: polyphenolic compounds in terms of gallic acid - 65.0, vitamin B1 - 1.5, vitamin B12 - 5.0 mkg, vitamin B6 - 1.5, isoflavones - 7, 5, L-glutathione - 50.0, zinc - 6.0, iron - 6.0, magnesium - 100, selenium - 50 mcg, eleutherosides, arnuzide - qualitative identification.
Capsules: magnesium oxide, clover grass extract, L-glutathione, iron gluconate, zinc gluconate, saccharose vinex extract, eleutherococcus spittle extract, cyanocobalamin, pyridoxine hydrochloride, thiamine hydrochloride, sodium selenite, E551, E470, gelatin.
Tablets: magnesium oxide, clover grass extract, L-glutathione, iron gluconate, zinc gluconate, saccharose vinex extract, eleutherococcus spittle extract, cyanocobalamin, pyridoxine hydrochloride, thiamine hydrochloride, sodium selenite, E551, E470.
Scope: & nbspfor the realization of a source of isoflavones, polyphenolic compounds (in terms of gallic acid), an additional source of mineral substances (zinc, magnesium, iron, selenium) and vitamins (B1, B6, B12) containing L-glutathione.
Suggested Usage: & nbspadult women 1 capsule (or tablet) per day with meals. Duration of admission is 2-3 weeks. If necessary, the reception can be repeated. Repeated receptions are possible throughout the year.
Contraindications: individual intolerance of components, pregnancy, breast-feeding, increased nervous excitability, insomnia, high blood pressure, cardiac rhythm disturbance, severe atherosclerosis. Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Keep in a dry place, protected from direct sunlight and out of the reach of children, at a temperature not exceeding 25 ° C.
Research protocols:expert conclusion of the FGBM of the Federal Target Program and the Federal Service for Consumer Rights Protection No. 10-2FTS / 3876 of 24.09.2015.
Recipient:Arttechnology, LLCArttechnology, LLC Russian Federation
Information update date: & nbsp02.04.2016
Instructions
Up